Evidence map›Paper›PMID 35464639›Full record

ArticleJournal of pharmacy practice and research : official journal of the Society of Hospital Pharmacists of Australia2021

Public hesitancy to COVID-19 vaccine and the role of pharmacists in addressing the problem and improving uptake.

Befikadu L Wubishet, Wubshet H Tesfaye, Md Nuruzzaman Khan, Jackson Thomas, Haitham Tuffaha, Tracy A Comans, Paul Scuffham, Daniel A Erku

Open access · bronzeAbstract read
In one paragraph

Article in Journal of pharmacy practice and research : official journal of the Society of Hospital Pharmacists of Australia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Befikadu L WubishetCentre for Health Services Research The University of Queensland Brisbane Australia.ORCID https://orcid.org/0000-0001-9896-8893
Wubshet H TesfayeHealth Research Institute University of Canberra Canberra Australia.
Md Nuruzzaman KhanDepartment of Population Science Jatiya Kabi Kazi Nazrul Islam University Mymensingh Bangladesh.
Jackson ThomasPharmacy Faculty of Health University of Canberra Canberra Australia.
Haitham TuffahaCentre for the Business and Economics of Health Faculty of Business, Economics and Law University of Queensland Brisbane Australia.
Tracy A ComansCentre for Health Services Research The University of Queensland Brisbane Australia.
Paul ScuffhamCentre for Applied Health Economics Griffith University Nathan Australia.
Daniel A ErkuCentre for Applied Health Economics Griffith University Nathan Australia.
Griffith University · AUThe University of Queensland · AUUniversity of Canberra · AUJatiya Kabi Kazi Nazrul Islam University · BDQueensland University of Technology · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 is one of the worst pandemics in recent human history, causing huge health, economic, and psychosocial damage. Since the pandemic hit, several unsubstantiated claims regarding exposure, transmission and management have been disseminated. Misinformation and associated public confusion now extend to the COVID-19 vaccines, spanning from claims based on possible links between some vaccine types and rare blood clots, to baseless claims. As a result, the public's trust in COVID-19 vaccines has been eroded, fuelling an already troubling trend of vaccine hesitancy. As medication experts and the most accessible healthcare providers, pharmacists are well equipped with the required skills and knowledge to improve COVID-19 vaccine uptake by taking roles that range from dispelling myths, to providing reliable evidence-based information, through to vaccine administration. This paper discusses public hesitancy to COVID-19 vaccines, major contributing factors, and the role pharmacists can play in reducing hesitancy and increasing vaccine uptake.

Indexed as

clinical pharmacistsCOVID‐19pharmacistspharmacy practicevaccine hesitancy

Identifiers

PMID35464639
PMCPMC9015492
OpenAlexW4200569935

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.